{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:12:41Z","timestamp":1784826761490,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inactivated Polio Vaccine (IPV) campaign was conducted in February 2019 in Karachi where needle-free injectors were introduced for the administration of the fractional dose of IPV (fIPV) on a large scale. This study aimed to determine the impact of needle-free injectors on vaccination coverage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In four towns of Karachi, fIPV was given using needle-free injectors \u201cPharmaJet Tropis ID\u201d. Whereas, in six towns full dose of IPV was administered to children of 4\u201359\u2009months of age. Cluster surveys through rapid convenience assessment method were conducted after the completion of vaccination activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 33,815 households\u2019 data was analyzed. Among these, 27,650 (82.8%) children were vaccinated. In fIPV areas, 85.3% of children were vaccinated compared to 79.5% in full dose IPV areas. A comparison of reasons for unvaccinated showed that 1.6% of parents do not give importance to vaccination in fIPV areas compared to 4.2% in full IPV areas (<jats:italic>p<\/jats:italic>-value &lt;\u20090.0001). More children were not vaccinated due to fear of injection 1.8% in full IPV areas compared to 0.7% in fIPV areas (<jats:italic>p<\/jats:italic>-value &lt;\u20090.0001). The source of campaign information shows that more frequent mobile miking 3.1% was observed in fIPV areas compared to 0.4% in full IPV areas (<jats:italic>p<\/jats:italic>-value &lt;\u20090.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our analysis supports the fractional dose of IPV in mass campaigns to achieve good vaccination coverage especially using needle-free injectors \u201cPharmaJet\u00a0Tropis ID\u201d and vigorous social mobilization activities are expedient in accomplishing high coverage.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-020-10041-8","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T20:05:26Z","timestamp":1609963526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh,\u00a0Pakistan"],"prefix":"10.1186","volume":"21","author":[{"given":"Umar Farooq","family":"Bullo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3239-8968","authenticated-orcid":false,"given":"Jaishri","family":"Mehraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Musa","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumaila","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noreen Naz","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ali","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zamir Ali","family":"Phul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail Ahmed","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan Iqbal","family":"Baloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahoor Ahmed","family":"Baloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoukat Ali","family":"Chandio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"10041_CR1","volume-title":"Wild poliovirus list: list of wild poliovirus by country and year","author":"Global Polio Eradication Initiative","year":"2019","unstructured":"Global Polio Eradication Initiative. Wild poliovirus list: list of wild poliovirus by country and year. 2019; Available from http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Wildpolioviruslist.aspx."},{"issue":"11","key":"10041_CR2","first-page":"237","volume":"63","author":"MA Sheikh","year":"2014","unstructured":"Sheikh MA, Makokha F, Hussein MA, Mohamed G, Mach O, Humayun K, et al. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities\u2014Kenya, December 2013. MMWR Morb Mortal Wkly Rep. 2014;63(11):237\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"01","key":"10041_CR3","first-page":"1","volume":"89","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Meeting of the strategic advisory group of experts on immunization, November 2013: conclusions and recommendations. Wkly Epidemiol Rec. 2014;89(01):1\u201320.","journal-title":"Wkly Epidemiol Rec"},{"issue":"22","key":"10041_CR4","first-page":"261","volume":"90","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Meeting of the strategic advisory group of experts on immunization, April 2015: conclusions and recommendations. Wkly Epidemiol Rec. 2015;90(22):261\u201380.","journal-title":"Wkly Epidemiol Rec"},{"issue":"2","key":"10041_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3201\/eid2302.161210","volume":"23","author":"G Shirreff","year":"2017","unstructured":"Shirreff G, Wadood MZ, Vaz RG, Sutter RW, Grassly NC. Estimated effect of inactivated poliovirus vaccine campaigns, Nigeria and Pakistan, January 2014\u2013April 2016. Emerg Infect Dis. 2017;23(2):258\u201363. https:\/\/doi.org\/10.3201\/eid2302.161210.","journal-title":"Emerg Infect Dis"},{"issue":"suppl_1","key":"10041_CR6","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1093\/infdis\/jix133","volume":"216","author":"K Fahmy","year":"2017","unstructured":"Fahmy K, Hampton LM, Langar H, Patel M, Mir T, Soloman C, et al. Introduction of inactivated polio vaccine, withdrawal of type 2 oral polio vaccine, and routine immunization strengthening in the Eastern Mediterranean Region. J Infect Dis. 2017;216(suppl_1):S86\u201393. https:\/\/doi.org\/10.1093\/infdis\/jix133.","journal-title":"J Infect Dis"},{"key":"10041_CR7","first-page":"73","volume":"89","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Polio vaccines: WHO position paper, January 2014. Wkly Epidemiol Rec. 2014;89:73\u201392.","journal-title":"Wkly Epidemiol Rec"},{"issue":"25","key":"10041_CR8","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","volume":"362","author":"AJ Mohammed","year":"2010","unstructured":"Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MM, et al. Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med. 2010;362(25):2351\u20139.","journal-title":"N Engl J Med"},{"issue":"48","key":"10041_CR9","doi-asserted-by":"publisher","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","volume":"33","author":"A Anand","year":"2015","unstructured":"Anand A, Zaman K, Est\u00edvariz CF, Yunus M, Gary HE, Weldon WC, et al. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial. Vaccine. 2015;33(48):6816\u201322. https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.039.","journal-title":"Vaccine."},{"issue":"2","key":"10041_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.vaccine.2014.11.025","volume":"33","author":"S Resik","year":"2015","unstructured":"Resik S, Tejeda A, Mach O, Fonseca M, Diaz M, Alemany N, et al. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba. Vaccine. 2015;33(2):307\u201313. https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.025.","journal-title":"Vaccine."},{"key":"10041_CR11","doi-asserted-by":"publisher","unstructured":"Snider CJ, Zaman K, Estivariz CF, Yunus M, Weldon WC, Wannemuehler KA, et al. Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial. Lancet. 2019. https:\/\/doi.org\/10.1016\/S0140-6736(19)30503-3.","DOI":"10.1016\/S0140-6736(19)30503-3"},{"issue":"12","key":"10041_CR12","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/infdis\/jiz026","volume":"219","author":"D Gamage","year":"2019","unstructured":"Gamage D, Mach O, Ginige S, Weldon WC, Oberste MS, Jeyaseelan V, et al. Poliovirus type 2 seroprevalence following full-or fractional-dose inactivated poliovirus vaccine in the period after Sabin type 2 withdrawal in Sri Lanka. J Infect Dis. 2019;219(12):1887\u201392. https:\/\/doi.org\/10.1093\/infdis\/jiz026.","journal-title":"J Infect Dis"},{"key":"10041_CR13","unstructured":"Product information. PharmaJet\u2019s Tropis needleless injection device is safe, fast and easy. Available from: https:\/\/pharmajet.com\/tropis-id\/ [Accessed 14 Nov 2020]."},{"key":"10041_CR14","doi-asserted-by":"publisher","unstructured":"Daly C, Molodecky NA, Sreevatsava M, Belayneh AD, Chandio SA, Partridge J, et al. Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: a survey of caregiver and vaccinator acceptability. Vaccine. 2019. https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.059.","DOI":"10.1016\/j.vaccine.2019.12.059"},{"issue":"47","key":"10041_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.15585\/mmwr.mm6647a4","volume":"66","author":"A Pervaiz","year":"2017","unstructured":"Pervaiz A, Mbaeyi C, Baig MA, Burman A, Ahmed JA, Akter S, et al. Fractional-dose inactivated poliovirus vaccine campaign\u2014Sindh Province, Pakistan, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(47):1295\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm6647a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10041_CR16","doi-asserted-by":"publisher","first-page":"e00395","DOI":"10.1016\/j.heliyon","volume":"3","author":"MT Yousafzai","year":"2017","unstructured":"Yousafzai MT, Saleem AF, Mach O, Baig A, Sutter RW, Zaidi AK. Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle-free injection system, Karachi, Pakistan. Heliyon. 2017;3(8):e00395. https:\/\/doi.org\/10.1016\/j.heliyon 2017. e00395. eCollection 2017 Aug.","journal-title":"Heliyon"},{"issue":"24","key":"10041_CR17","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1016\/j.vaccine.2017.04.075","volume":"35","author":"AF Saleem","year":"2017","unstructured":"Saleem AF, Mach O, Yousafzai MT, Khan A, Weldon WC, Oberste MS, et al. Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: evaluation of immunogenicity and programmatic feasibility in Pakistan. Vaccine. 2017;35(24):3209\u201314. https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.075.","journal-title":"Vaccine."},{"issue":"33","key":"10041_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.15585\/mmwr.mm6533a5","volume":"65","author":"S Bahl","year":"2016","unstructured":"Bahl S, Verma H, Bhatnagar P, Haldar P, Satapathy A, Kumar KN, et al. Fractional-dose inactivated poliovirus vaccine immunization campaign - Telangana State, India, June 2016. MMWR Morb Mortal Wkly Rep. 2016;65(33):859\u201363. https:\/\/doi.org\/10.15585\/mmwr.mm6533a5.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10041_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/infdis\/175.Supplement_1.S215","volume":"74","author":"WHO Collaborative Study Group","year":"1996","unstructured":"WHO Collaborative Study Group. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in the Gambia, Oman, and Thailand. Bull World Health Organ. 1996;74(3):253\u201368. https:\/\/doi.org\/10.1093\/infdis\/175.Supplement_1.S215.","journal-title":"Bull World Health Organ"},{"issue":"9","key":"10041_CR20","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1086\/651611","volume":"201","author":"S Resik","year":"2010","unstructured":"Resik S, Tejeda A, Mas Lago P, Diaz M, Carmenates A, Sarmiento L, et al. Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba. J Infect Dis. 2010;201(9):1344\u201352. https:\/\/doi.org\/10.1086\/651611.","journal-title":"J Infect Dis"},{"issue":"11","key":"10041_CR21","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.vaccine.2020.01.072","volume":"38","author":"A Yufika","year":"2020","unstructured":"Yufika A, Wagner AL, Nawawi Y, Wahyuniati N, Anwar S, Yusri F, et al. Parents\u2019 hesitancy towards vaccination in Indonesia: a cross-sectional study in Indonesia. Vaccine. 2020;38(11):2592\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.072.","journal-title":"Vaccine."},{"issue":"6","key":"10041_CR22","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.1016\/S2214-109X(17)30184-5","volume":"5","author":"MA Habib","year":"2017","unstructured":"Habib MA, Soofi S, Cousens S, Anwar S, Haque NU, Ahmed I, et al. Community engagement and integrated health and polio immunization campaigns in conflict-affected areas of Pakistan: a cluster randomized controlled trial. Lancet Glob Health. 2017;5(6):e593\u2013603. https:\/\/doi.org\/10.1016\/S2214-109X(17)30184-5.","journal-title":"Lancet Glob Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-10041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-020-10041-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-10041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T20:53:26Z","timestamp":1609966406000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-10041-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10041"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-10041-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"27 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used secondary data of the Inactivated Polio Vaccine (IPV) campaign which was collected by the Emergency Operations Centre (EOC) for Polio Eradication and Immunization, Health department, Sindh Government, Pakistan. Approval has been obtained from the ERB of Health Department Government of Sindh, Pakistan; before the acquisition of IPV campaign data of EOC Sindh for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author (s) declares that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}